Cathie Wood: portfolio of ARK Investment Management
Cathie Wood leads ARK Investment Management, which offers actively managed funds focused on technology and innovation.
Source: 13F filing with the US Securities and Exchange Commission dated Jul 11, 2022. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q2 2022. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 16.8B USD
- Positions
- 339
- Share of the ten largest
- 46.4%
The ten largest positions Q2 2022
- Tesla, Inc. 6.5%▼ −9.5%
- Zoom Video Communications Inc 6.1%▲ +13.8%
- Roku Inc 5.7%▲ +22.6%
- Block, Inc. 4.7%▲ +10.0%
- Exact Sciences Corp 4.4%▲ +4.5%
- Coinbase 4.2%▲ +28.2%
- Teladoc Health Inc 4.1%▲ +4.2%
- UiPath Inc 3.8%▲ +11.9%
- Twilio 3.5%▲ +11.0%
- CRISPR Therapeutics AG 3.4%▲ +3.4%
Show all positions of this quarter
Choose a quarter (40 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
All positions Q2 2022
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| XYZ Block, Inc. | 4.7% | 9,135,579 | 799.5M USD | +10.0% increased | Q4 2016 or earlier 23 quarters |
| Intellia Therapeutics Inc | 2.6% | 9,514,580 | 439.0M USD | +5.9% increased | Q4 2016 or earlier 23 quarters |
| Stratasys Ltd | 1.0% | 8,173,499 | 163.0M USD | +5.3% increased | Q4 2016 or earlier 23 quarters |
| Veracyte Inc | 0.9% | 8,856,245 | 155.7M USD | +1.1% increased | Q4 2016 or earlier 23 quarters |
| Invitae Corp | 0.6% | 28,668,950 | 105.2M USD | +3.6% increased | Q4 2016 or earlier 23 quarters |
| Materialise NV | 0.5% | 6,201,169 | 90.7M USD | +5.1% increased | Q4 2016 or earlier 23 quarters |
| 2U Inc | 0.5% | 9,586,065 | 89.3M USD | +4.3% increased | Q4 2016 or earlier 23 quarters |
| Cerus Corp | 0.5% | 17,111,062 | 84.7M USD | +5.5% increased | Q4 2016 or earlier 23 quarters |
| MELI MercadoLibre | 0.4% | 96,430 | 75.8M USD | +1.5% increased | Q4 2016 or earlier 23 quarters |
| TER Teradyne | 0.3% | 444,886 | 48.6M USD | +16.7% increased | Q4 2016 or earlier 23 quarters |
| Compugen Ltd | 0.1% | 10,781,621 | 19.9M USD | +5.4% increased | Q4 2016 or earlier 23 quarters |
| ADSK Autodesk | < 0.1% | 44,254 | 9.2M USD | +4.0% increased | Q4 2016 or earlier 23 quarters |
| FARO Technologies Inc | < 0.1% | 185,352 | 6.0M USD | +2.9% increased | Q4 2016 or earlier 23 quarters |
| ALGN Align Technology | < 0.1% | 10,462 | 2.9M USD | +1.1% increased | Q4 2016 or earlier 23 quarters |
| CRISPR Therapeutics AG | 3.4% | 9,727,531 | 564.7M USD | +3.4% increased | Q2 2017 21 quarters |
| Teladoc Health Inc | 4.1% | 20,293,962 | 691.8M USD | +4.2% increased | Q3 2017 20 quarters |
| Toray Industries Inc | < 0.1% | 57,803 | 300.0K USD | +7.2% increased | Q3 2017 20 quarters |
| Nova Ltd | < 0.1% | 21,761 | 2.3M USD | +0.9% increased | Q4 2017 19 quarters |
| Nice Ltd | < 0.1% | 10,567 | 2.1M USD | +6.1% increased | Q4 2017 19 quarters |
| Camtek Ltd/Israel | < 0.1% | 71,116 | 2.1M USD | +4.2% increased | Q4 2017 19 quarters |
| AudioCodes Ltd | < 0.1% | 90,288 | 2.1M USD | +4.3% increased | Q4 2017 19 quarters |
| Taro Pharmaceutical Industries | < 0.1% | 55,940 | 2.0M USD | +0.7% increased | Q4 2017 19 quarters |
| Danel Adir Yeoshua Ltd | < 0.1% | 13,252 | 1.8M USD | +18.1% increased | Q4 2017 19 quarters |
| Wix.com Ltd | < 0.1% | 26,038 | 1.6M USD | +31.4% increased | Q4 2017 19 quarters |
| Sapiens International Corp NV | < 0.1% | 88,992 | 2.3M USD | +4.0% increased | Q3 2018 16 quarters |
| TWLO Twilio | 3.5% | 5,572,436 | 586.1M USD | +11.0% increased | Q4 2018 15 quarters |
| Codexis Inc | 0.3% | 4,486,573 | 47.9M USD | +13.8% increased | Q4 2018 15 quarters |
| Roku Inc | 5.7% | 10,144,564 | 962.7M USD | +22.6% increased | Q2 2019 13 quarters |
| Fate Therapeutics Inc | 1.6% | 11,473,655 | 265.0M USD | +4.4% increased | Q2 2019 13 quarters |
| Twist Bioscience Corp | 1.3% | 6,267,721 | 213.4M USD | +19.1% increased | Q2 2019 13 quarters |
| CareDx Inc | 0.6% | 3,995,450 | 100.5M USD | +13.8% increased | Q2 2019 13 quarters |
| Personalis Inc | 0.1% | 5,347,820 | 21.2M USD | +3.1% increased | Q2 2019 13 quarters |
| OC Oerlikon Corp AG | < 0.1% | 420,753 | 3.2M USD | +18.4% increased | Q2 2019 13 quarters |
| Allot Ltd | < 0.1% | 357,287 | 1.9M USD | +41.6% increased | Q2 2019 13 quarters |
| Henkel AG & Co KGaA | < 0.1% | 4,449 | 304.0K USD | +14.7% increased | Q2 2019 13 quarters |
| Pacific Biosciences of Califor | 0.9% | 28,045,530 | 157.9M USD | +2.9% increased | Q3 2019 12 quarters |
| Siemens AG | < 0.1% | 24,235 | 3.2M USD | +11.0% increased | Q3 2019 12 quarters |
| Fiverr International Ltd | < 0.1% | 40,565 | 1.7M USD | +22.9% increased | Q3 2019 12 quarters |
| SGL Carbon SE | < 0.1% | 52,968 | 329.0K USD | +20.5% increased | Q3 2019 12 quarters |
| Arkema SA | < 0.1% | 2,441 | 295.0K USD | +7.3% increased | Q3 2019 12 quarters |
| Sandvik AB | < 0.1% | 14,171 | 290.0K USD | +12.5% increased | Q3 2019 12 quarters |
| Evonik Industries AG | < 0.1% | 10,742 | 287.0K USD | +4.3% increased | Q3 2019 12 quarters |
| Inmode Ltd | < 0.1% | 73,637 | 2.0M USD | +29.0% increased | Q4 2019 11 quarters |
| PagerDuty Inc | 1.6% | 10,882,979 | 268.3M USD | +6.0% increased | Q1 2020 10 quarters |
| 10X Genomics Inc | 1.1% | 3,603,286 | 184.5M USD | +6.2% increased | Q2 2020 9 quarters |
| Schrodinger Inc/United States | 0.5% | 2,953,172 | 76.3M USD | +4.3% increased | Q2 2020 9 quarters |
| Adaptive Biotechnologies Corp | 0.4% | 8,773,018 | 68.6M USD | +13.8% increased | Q2 2020 9 quarters |
| Exact Sciences Corp | 4.4% | 14,971,765 | 745.7M USD | +4.5% increased | Q3 2020 8 quarters |
| Unity Software Inc | 2.2% | 9,175,711 | 366.8M USD | +11.3% increased | Q3 2020 8 quarters |
| Berkeley Lights Inc | 0.2% | 8,422,424 | 40.3M USD | +1.5% increased | Q3 2020 8 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Show more (up to 500) Shown: the 50 longest-held of 98 positions.
Plus 15 option positions, value of the underlying shares as reported 66.3M USD – not included in the weights.
The filing states the value of the shares the options refer to. Whether a put is a hedge or a bet on falling prices is not stated in the filing.
- SomaLogic Inc Call 62.0M USD
- Energy Select Sector SPDR Fund Put 1.7M USD
- Zoom Video Communications Inc Call 989.0K USD
- ARK Innovation ETF Call 370.0K USD
- Tesla, Inc. Call 303.0K USD
- Block, Inc. Call 236.0K USD
- Coinbase Call 172.0K USD
- DraftKings Call 134.0K USD
- Roku Inc Call 114.0K USD
- CRISPR Therapeutics AG Call 75.0K USD
Breakdown by sector
- Financials 11.0%
- Consumer Discretionary 6.6%
- Technology 6.1%
- Health Care 2.0%
- Industrials 1.1%
- Communication Services 0.2%
- Materials < 0.1%
- Consumer Staples < 0.1%
- not in our coverage 72.8%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors